Steven M Paul - Net Worth and Insider Trading
Steven M Paul Net Worth
The estimated net worth of Steven M Paul is at least $173 Million dollars as of 2025-07-14. Steven M Paul is the Director of Bright Horizons Family Solutions Inc and owns about 763,650 shares of Bright Horizons Family Solutions Inc (BFAM) stock worth over $88 Million. Steven M Paul is the EVP, Science and Technology of Eli Lilly and Co and owns about 50,300 shares of Eli Lilly and Co (LLY) stock worth over $40 Million. Steven M Paul is also the PRESIDENT & CEO of Karuna Therapeutics Inc and owns about 108,849 shares of Karuna Therapeutics Inc (KRTX) stock worth over $36 Million. Besides these, Steven M Paul also holds Sage Therapeutics Inc (SAGE) , Voyager Therapeutics Inc (VYGR) , Alnylam Pharmaceuticals Inc (ALNY) . Details can be seen in Steven M Paul's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven M Paul has not made any transactions after 2021-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven M Paul
Steven M Paul Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven M Paul owns 5 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Karuna Therapeutics Inc (KRTX) , and Sage Therapeutics Inc (SAGE) among others .
Click here to see the complete history of Steven M Paul’s form 4 insider trades.
Insider Ownership Summary of Steven M Paul
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2020-12-18 | director |
| KRTX | Karuna Therapeutics Inc | 2021-08-18 | director & President & CEO |
| SAGE | Sage Therapeutics Inc | 2019-03-21 | director |
 | | 2016-01-14 | director & President and CEO |
| | 2008-02-04 | EVP & Science and Technology |
Steven M Paul Latest Holdings Summary
Steven M Paul currently owns a total of 6 stocks. Among these stocks, Steven M Paul owns 763,650 shares of Bright Horizons Family Solutions Inc (BFAM) as of May 1, 2015, with a value of $88 Million and a weighting of 50.85%. Steven M Paul owns 50,300 shares of Eli Lilly and Co (LLY) as of February 4, 2008, with a value of $40 Million and a weighting of 23.03%. Steven M Paul also owns 108,849 shares of Karuna Therapeutics Inc (KRTX) as of August 18, 2021, with a value of $36 Million and a weighting of 20.72%. The other 3 stocks Sage Therapeutics Inc (SAGE) , Voyager Therapeutics Inc (VYGR) , Alnylam Pharmaceuticals Inc (ALNY) have a combined weighting of 5.4% among all his current holdings.
Latest Holdings of Steven M Paul
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BFAM | Bright Horizons Family Solutions Inc | 2015-05-01 | 763,650 | 115.35 | 88,087,028 |
| LLY | Eli Lilly and Co | 2008-02-04 | 50,300 | 793.01 | 39,888,403 |
| KRTX | Karuna Therapeutics Inc | 2021-08-18 | 108,849 | 329.83 | 35,901,666 |
| SAGE | Sage Therapeutics Inc | 2019-03-21 | 646,830 | 9.27 | 5,996,114 |
| VYGR | Voyager Therapeutics Inc | 2016-01-14 | 872,351 | 3.49 | 3,044,505 |
| ALNY | Alnylam Pharmaceuticals Inc | 2020-12-18 | 1,000 | 314.94 | 314,940 |
Holding Weightings of Steven M Paul
Steven M Paul Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven M Paul has made a total of 0 transactions in Bright Horizons Family Solutions Inc (BFAM) over the past 5 years. The most-recent trade in Bright Horizons Family Solutions Inc is the sale of 20,000 shares on May 1, 2015, which brought Steven M Paul around $1 Million.
According to the SEC Form 4 filings, Steven M Paul has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 19,822 shares on February 4, 2008, which brought Steven M Paul around $1 Million.
According to the SEC Form 4 filings, Steven M Paul has made a total of 1 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 2,364 shares on August 18, 2021, which cost Steven M Paul around $250,253.
More details on Steven M Paul's insider transactions can be found in the Insider Trading History of Steven M Paul table.Insider Trading History of Steven M Paul
- 1
Steven M Paul Trading Performance
GuruFocus tracks the stock performance after each of Steven M Paul's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven M Paul is -0.42%. GuruFocus also compares Steven M Paul's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven M Paul within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven M Paul's insider trading performs compared to the benchmark.
Performance of Steven M Paul
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.79 | | | | | |
| Relative Return to S&P 500(%) | -5 | | | | | |
Steven M Paul Ownership Network
Ownership Network List of Steven M Paul
Ownership Network Relation of Steven M Paul
Steven M Paul Owned Company Details
What does Alnylam Pharmaceuticals Inc do?
Who are the key executives at Alnylam Pharmaceuticals Inc?
Steven M Paul is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & Chief Commercial Officer Tolga Tanguler .
Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary
Over the past 18 months, Steven M Paul made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 112,620 shares made by Yvonne Greenstreet , a net sale of 75,070 shares made by Pushkal Garg , and a net sale of 31,577 shares made by Kevin Joseph Fitzgerald .
In summary, during the past 3 months, insiders sold 62,223 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 62,223 shares. During the past 18 months, 375,510 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 36 shares were bought by its insiders, resulting in a net sale of 375,474 shares.
Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alnylam Pharmaceuticals Inc Insider Transactions
Steven M Paul Mailing Address
Above is the net worth, insider trading, and ownership report for Steven M Paul. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Steven M Paul's mailing address is: Indianapolis In 46285.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
